[ 1 ]       Ruenraroengsak P, Cook J M, Florence A T. Nanosystem drug tar-
geting: facing up to complex realities[ J ]. J Con Rel, 2010, 141( 3 ): 265 - 276.
[ 2 ]       Robinson D R, Wu Y M, Lin S F. The protein tyrosine kinase fam-
ily of the human genome[ J ]. Oncogene, 2000, 19( 49 ): 5 548 - 5 557.
[ 3 ]       Lemmon M A, Schlessinger J. Cell signaling by receptor tyrosine
kinases[ J ]. Cell, 2010, 141( 7 ): 1 117 - 1 134.
[ 4 ]       Moslehi J J, Deininger M. Tyrosine kinase inhibitor-associated ca-
rdiovaseular toxicity in chronic myeloid leukemia[ J ]. JClin Oncol, 2015, 33( 35 ): 4 210 - 4 218.
[ 5 ]       Ciardiello F, De Vita F, Orditura M, et al. Epidermal growth factor receptor tyrosine kinase inhibitoes in late stage clinical[ J ]. Exp Opin Emerg Drugs, 2003（ 8 ）: 501 - 514.
[ 6 ]       Fry D W, Kraker A J, McMichael A, et al. A specific inhibitor of the novel epidermal growth factor receptor tyrosine kinase[ J ]. Science, 1994, 265(5 175): 1 093 - 1 095.
[ 7 ]       Tan F, Shi Y, Wang Y, et al. Icotinib a selective EGF receptor tyr-
osine kinase inhibitor, for the treatment of non-small-cell lung eancer[ J ]. Future Oncol, 2015,11( 3 ): 385 - 397.
[ 8 ]       张    华，赵金浩，王    晖. 4-（3-氯-4-氟苯氨基）-7-甲氧基-6-[3-（4-吗啉基）-丙氧基]喹啉的合成法：CN101402610A[ P ].
[ 9 ]       李文倩，宋国强，万屹东，等. 阿法替尼的合成工艺改进[ J ]. 合成化学，2017，25（ 2 ）：166 - 169.
[ 10 ]     许学农. 阿法替尼的制备方法：中国，CN201310182778. 4[ P ].
[ 11 ]     Yu H A, Tian S K, Drilon A E, et al. Acquired resistance of EGFR
-mutant lung cancer to a T790Mspecific EGFR inhibitor: Emergence of a third mutation (C797S) in the EGFR tyrosine kinase domain[ J ]. JAMA Oncol, 2015, 1( 7 ): 982 - 984.
[ 12 ]     张星贤，孙莉琼，戚    进. 酪氨酸激酶抑制剂类小分子抗肿瘤药物的研究进展[ J ]. Chinese Journaf of New D rugs，2018，27（ 22 ）：2 616 - 2 629.
[ 13 ]     Pawar V G, Sos M L, Rode H B, et al. Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor[ J ]. J Med Chem, 2010（ 53 ）: 2 892 - 2 901.
[ 14 ]     Carmi C, Cavazzoni A, Vezzosi S, et al.Novel irreversible epiderm-
al growth factor receptor inhibitors by chemical modulation of the cysteine-trap portion[ J ]. J Med Chem, 2010（ 53 ）: 2 038 - 2 050.
[ 15 ]     薛子溪，陈国术. 含喹唑啉-芳基哌嗪结构新型抗肿瘤药物的设计合成[ J ]. 化学工程与装备，2017（ 5 ）：10 - 11.
[ 16 ]     孟祥川，栗    娜，李二冬，等. 2-甲硫基-4-芳胺喹唑啉衍生物的合成及抗肿瘤活性评价[ J ]. Chin J Org Chem, 2018（ 38 ）：3 063 - 3 069.